Clinical Trials Logo

Cigarette Smoking clinical trials

View clinical trials related to Cigarette Smoking.

Filter by:

NCT ID: NCT06032793 Not yet recruiting - Cigarette Smoking Clinical Trials

Effects of Deep Breathing Exercise on Pulmonary Function, Perceived Stress and Physical Fitness.

Start date: September 1, 2023
Phase: N/A
Study type: Interventional

Effects of deep breathing exercise on pulmonary function, perceived stress and physical fitness among healthy smokers.

NCT ID: NCT06027840 Recruiting - Smoking Cessation Clinical Trials

Concurrent vs. Sequential Cessation of Dual Cigarette and E-cigarette Use

Start date: April 1, 2024
Phase: Phase 1
Study type: Interventional

The purpose of this research study is to understand whether concurrent treatment for cigarettes and e-cigarettes in which an individual quits both products at the same time (QUIT-C) or sequential treatment in which an individual quits cigarettes first followed by e-cigarettes is more effective for quitting both products. The study will also compare the effect of treatment on health-related biomarkers. All participants will receive varenicline, a medication used to treat tobacco use dependence, counseling, and cessation resources (i.e., links to text-based support, self-change booklet). Varenicline helps to reduce cravings for tobacco use and decreases the pleasurable effects of cigarettes and other tobacco products.

NCT ID: NCT06001840 Recruiting - Cigarette Smoking Clinical Trials

Promotion and Mitigation Factors Leading to Illegal Tobacco Purchases

Start date: January 4, 2024
Phase: N/A
Study type: Interventional

This study will investigate the effects of promotion factors and mitigation strategies on legal and illegal tobacco purchases for different tobacco-user types.

NCT ID: NCT05958992 Completed - Cigarette Smoking Clinical Trials

Effects of e-Cigarettes on Perceptions and Behavior - Remote Substudy # 2

Start date: August 25, 2020
Phase: N/A
Study type: Interventional

This study assess the ways in which e-cigarette product characteristics, such as flavors and nicotine salts, impact user experience to inform potential regulations.

NCT ID: NCT05958979 Completed - Cigarette Smoking Clinical Trials

Effects of e-Cigarettes on Perceptions and Behavior - Remote Substudy # 1

Start date: August 25, 2020
Phase: N/A
Study type: Interventional

This study assess the ways in which e-cigarette product characteristics, such as marketing strategies, impact user experience to inform potential regulations.

NCT ID: NCT05958966 Completed - Cigarette Smoking Clinical Trials

Effects of e-Cigarettes on Perceptions and Behavior - Substudy 2

Start date: April 1, 2022
Phase: N/A
Study type: Interventional

This project will assess the ways in which e-cigarette product diversity impacts the user experience to inform potential regulations by identifying product characteristics that may: (1) put young adults at risk for tobacco product use; and (2) facilitate adult smokers switching to e-cigarettes. There are three primary objectives to the study: (1) Determine which dimensions of e-cigarette product diversity differentially affect product appeal in the overall population of tobacco product users as well as affect product appeal across young adult e-cigarette users and middle-age/older adult smokers; (2) Determine which dimensions of e-cigarette product diversity differentially affect product appeal in the overall population of tobacco product users as well as affect abuse liability in young adult e-cigarette users and the ability to resist smoking in adult smokers; (3) Determine the affect of product characteristics on e-cigarette nicotine delivery profile. For this substudy, adult smokers (N=200) will attend two laboratory session in which they will self-administer e-cigarette products varied according to within-subject e-cigarette factors (e.g., flavor, nicotine formulation) and smoke their own cigarettes.

NCT ID: NCT05946031 Not yet recruiting - Cigarette Smoking Clinical Trials

Testing the ETM: Examination and Comparison of Different Methods

Start date: June 1, 2024
Phase: N/A
Study type: Interventional

This study will experimentally assess the comparability of in-lab and remote procedures with hypothetical and real ETM purchase outcomes.

NCT ID: NCT05815199 Recruiting - Cigarette Smoking Clinical Trials

E-cigarettes for Harm Reduction Among Smokers With Serious Mental Illness

Start date: November 13, 2023
Phase: N/A
Study type: Interventional

In this open-label, randomized controlled trial study, participants who smoke combustible cigarettes (CC) and are diagnosed with Serious Mental Illness (SMI) will be randomized in two arms to receive harm-reduction counseling and Ecological Momentary Intervention text messaging (EMI) along with either e-cigarettes (EC) or nicotine replacement therapy (NRT) such as patch and lozenges to compare the efficacy in CC smoking reduction.

NCT ID: NCT05788068 Completed - Smoking Cessation Clinical Trials

Efficacy and Neuroimaging Mechanisms of Smoking Cessation in China

Start date: March 1, 2023
Phase: N/A
Study type: Interventional

This proposed project is to assess the efficacy of CBT-based digital smoking cessation interventions in China, as well as explore its neuroimaging mechanisms.

NCT ID: NCT05740098 Completed - Cigarette Smoking Clinical Trials

Financial Incentives for Smoking Cessation Among Mothers

Start date: June 2015
Phase: N/A
Study type: Interventional

Investigators will examine whether adding financial incentives and nicotine replacement dual therapy to current best practices for smoking cessation (i.e. referral to counseling using a telephone quit line) increases cessation rates in mothers and reduces second-hand smoke exposure in children. While perhaps more expensive upfront compared to best practices alone, the investigators hypothesize that this treatment approach will be a more cost-effective cessation intervention.